Impact of a Mediterranean Diet on Cardiovascular Disease Risk Factors
NCT06113484 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2023-11-07
Summary
This approved and funded research project is part of a larger project titled "Algarve Active Ageing - Cardiac and Osteoarthritis Rehabilitation (A3-COR): personalized exercise protocol in the rehabilitation after acute myocardial infarction or at risk of cardiovascular disease and knee osteoarthritis, a multicenter clinical intervention study".
The main objective of this work is to quantify the effect of a nutritional and physical activity intervention in improving important risk factors for cardiovascular disease, such as body weight, body composition, and waist circumference.
Conditions
- Cardiovascular Disease Risk
Interventions
- OTHER
-
DIET + EXERCISE
At first, a two-hour group session titled 'Discovering New Flavors' is conducted. This session aims to promote the consumption of healthy foods that should be included in the participants' daily diet. In order to create a different dynamic and enhance interaction, some recipe suggestions are prepared in a group setting. The intervention group is advised to have three (breakfast, lunch, and dinner) to four (breakfast, lunch, afternoon snack, and dinner) daily meals. Participants are encouraged not to count calories, thus emphasizing the importance of moderation. Regarding the main meals, legumes are recommended as a protein source for dinner. On the other hand, for lunch, the protein component can include white meats, fish, or eggs. Red and/or processed meats are excluded in this intervention. Moreover, all participants in this group are encouraged to practice a nightly fasting period of at least 12 hours.
- OTHER
-
WITHOUT DIET + EXERCISE
An educational session titled "Healthy Eating: Nutritional Recommendations for Individuals at Risk of Cardiovascular Disease" will be conducted in a group setting. The objective of this session is to raise awareness among participants about the importance of a healthy diet and lifestyle in the prevention of cardiovascular diseases.
Sponsors & Collaborators
-
Associação para o Desenvolvimento do Centro Académico de Investigação e Formação Biomédica do Algarv
collaborator NETWORK -
Universidade Católica Portuguesa
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-30
- Primary Completion
- 2023-12-29
- Completion
- 2023-12-29
Countries
- Portugal
Study Locations
More Related Trials
-
Myocardial Infarction Size Reduction With Atorvastatin
NCT00286312 ·Status: COMPLETED ·Phase: PHASE4
-
Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients
NCT00481364 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Atorvastatin and Lifestyle Intervention on Progression of Pre-Clinical Atherosclerosis
NCT00723320 ·Status: UNKNOWN ·Phase: NA
-
Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia
NCT06183307 ·Status: RECRUITING ·Phase: NA
-
Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease
NCT01946815 ·Status: COMPLETED ·Phase: PHASE3
-
Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)
NCT06922994 ·Status: RECRUITING ·Phase: PHASE2
-
Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects
NCT00345202 ·Status: COMPLETED ·Phase: PHASE4
-
EARly Prevention of aTHeroma Progression
NCT02105623 ·Status: TERMINATED ·Phase: PHASE4
-
The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy
NCT01213498 ·Status: COMPLETED ·Phase: PHASE2
-
the Change of Cholesterol Efflux Capacity and Coronary Artery Disease in Real Clinical Practice
NCT03389529 ·Status: UNKNOWN
-
Eliminate Coronary Artery Disease
NCT02245087 ·Status: TERMINATED ·Phase: PHASE2
-
The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment
NCT05803759 ·Status: UNKNOWN ·Phase: PHASE4
-
Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease
NCT02121054 ·Status: COMPLETED
-
Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery
NCT00791648 ·Status: COMPLETED ·Phase: NA
-
The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease
NCT02133534 ·Status: TERMINATED ·Phase: PHASE4
-
Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)
NCT01042730 ·Status: COMPLETED ·Phase: NA
-
The Surem TRAF3IP2 Level and Atherosclerotic Plaque Development in Human
NCT05945394 ·Status: UNKNOWN
-
Dietary Intervention to Stop COronary Atherosclerosis in Computed Tomography
NCT02571803 ·Status: UNKNOWN ·Phase: NA
-
Statins Evaluation in Coronary Procedures and Revascularization Trial
NCT01448642 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI
NCT02590653 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical Trial
NCT04777045 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Citrulline Efficacy to Improve Carbohydrate Metabolism Abnormalities in the Patient Treated With High Doses of Statin
NCT03596684 ·Status: COMPLETED ·Phase: NA
-
Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease
NCT06425120 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
NCT00715273 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanism and Intervention Research of Atherosclerosis
NCT05437107 ·Status: COMPLETED